Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Vertex Pharmaceuticals Inc., consolidated balance sheet: assets (quarterly data)

US$ in thousands

	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash and cash equivalents	6,143,500)	5,492,900)	5,084,800)	4,939,600)	4,972,200)	4,674,700)	4,569,600)	5,239,200)	4,580,100)	9,158,000)	10,369,100)	11,110,200)	10,151,100)	9,289,900)	10,504,000)	9,171,500)	8,702,200)	7,600,100)	6,795,000)	6,275,698)	6,063,678)	6,304,330)
Marketable securities	1,708,900)	1,753,800)	1,523,300)	1,347,400)	1,410,600)	1,526,500)	1,546,300)	1,285,300)	1,215,400)	1,013,300)	849,200)	818,000)	1,085,200)	1,124,200)	274,500)	599,200)	551,200)	638,000)	729,900)	685,187)	644,315)	619,638)
Accounts receivable, net	2,134,300)	1,996,100)	2,052,800)	1,946,400)	1,893,500)	1,805,100)	1,609,400)	1,750,600)	1,656,100)	1,793,200)	1,563,400)	1,538,700)	1,556,200)	1,547,800)	1,442,200)	1,385,200)	1,332,900)	1,292,800)	1,136,800)	1,100,372)	929,142)	977,551)
Inventories	1,765,100)	1,766,700)	1,686,800)	1,626,800)	1,499,300)	1,359,700)	1,205,400)	1,079,800)	914,600)	813,100)	738,800)	688,700)	603,500)	535,100)	460,600)	388,200)	367,700)	338,900)	353,100)	333,456)	321,620)	298,863)
Prepaid expenses and other current assets	791,900)	720,800)	853,300)	709,400)	652,300)	642,800)	665,700)	449,200)	575,400)	511,100)	623,700)	540,200)	476,900)	468,700)	553,500)	726,900)	549,500)	491,500)	545,800)	457,827)	498,759)	338,925)
Current assets	12,543,700)	11,730,300)	11,201,000)	10,569,600)	10,427,900)	10,008,800)	9,596,400)	9,804,100)	8,941,600)	13,288,700)	14,144,200)	14,695,800)	13,872,900)	12,965,700)	13,234,800)	12,271,000)	11,503,500)	10,361,300)	9,560,600)	8,852,540)	8,457,514)	8,539,307)
Property and equipment, net	1,665,000)	1,608,400)	1,520,300)	1,425,100)	1,335,100)	1,295,900)	1,227,800)	1,117,800)	1,200,900)	1,172,800)	1,159,300)	1,124,000)	1,122,400)	1,111,700)	1,108,400)	1,118,700)	1,100,100)	1,107,400)	1,094,100)	1,042,347)	1,021,233)	986,123)
Goodwill	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,075,200)	1,002,200)	1,002,200)	1,002,200)	1,002,158)	1,002,158)	1,002,158)
Other intangible assets, net	412,800)	418,500)	424,200)	429,800)	435,500)	441,200)	825,900)	831,600)	837,500)	834,900)	839,900)	603,600)	603,600)	603,600)	603,600)	603,600)	387,000)	400,000)	400,000)	400,000)	400,000)	400,000)
Deferred tax assets	3,010,900)	2,947,800)	2,897,900)	2,937,200)	2,711,700)	2,544,300)	2,331,100)	2,308,900)	2,185,600)	1,963,000)	1,812,100)	1,729,100)	1,538,000)	1,359,900)	1,246,900)	1,162,700)	1,143,800)	945,500)	934,500)	933,839)	952,808)	815,890)
Operating lease assets	1,662,900)	1,685,100)	1,562,700)	1,591,800)	1,313,800)	1,338,500)	1,356,800)	1,396,100)	569,800)	312,900)	293,600)	310,500)	324,300)	336,300)	347,400)	342,700)	318,300)	329,000)	330,300)	312,343)	316,874)	322,319)
Long-term marketable securities	5,789,100)	5,749,900)	5,712,300)	5,722,800)	5,645,900)	5,156,500)	5,107,900)	4,703,500)	4,393,100)	4,381,400)	2,497,800)	1,700,000)	1,357,300)	1,081,500)	112,200)	—)	—)	—)	—)	—)	—)	—)
Other assets	1,250,900)	1,256,400)	1,236,600)	1,098,000)	1,078,800)	1,007,300)	999,300)	990,200)	915,600)	875,700)	895,300)	475,200)	442,700)	427,500)	409,600)	132,500)	127,300)	110,700)	110,800)	75,518)	71,099)	49,262)
Long-term assets	14,879,600)	14,754,100)	14,442,000)	14,292,700)	13,608,800)	12,871,700)	12,936,800)	12,436,100)	11,190,500)	10,628,700)	8,586,000)	7,030,400)	6,476,300)	6,008,500)	4,916,100)	4,435,400)	4,078,700)	3,894,800)	3,871,900)	3,766,205)	3,764,172)	3,575,752)
Total assets	27,423,300)	26,484,400)	25,643,000)	24,862,300)	24,036,700)	22,880,500)	22,533,200)	22,240,200)	20,132,100)	23,917,400)	22,730,200)	21,726,200)	20,349,200)	18,974,200)	18,150,900)	16,706,400)	15,582,200)	14,256,100)	13,432,500)	12,618,745)	12,221,686)	12,115,059)

Total assets exhibit a sustained upward trajectory, growing from approximately 12.1 billion US dollars in March 2021 to 27.4 billion US dollars by June 2026. While the growth is generally consistent, a notable contraction occurred in the first quarter of 2024, where total assets declined to 20.1 billion US dollars from 22.7 billion US dollars in the preceding quarter, before resuming a recovery and growth phase.

Liquidity and Cash Management: Cash and cash equivalents peaked at 10.5 billion US dollars in December 2022. A significant reduction is observed starting in March 2024, with balances dropping to approximately 4.6 billion US dollars. Following this correction, cash levels stabilized and began a gradual ascent, reaching 6.1 billion US dollars by June 2026. This suggests a strategic reallocation of liquid capital toward other asset classes.
Operational Asset Scaling: There is a consistent and significant increase in assets tied to operations. Accounts receivable, net, grew from 977 million US dollars in March 2021 to 2.1 billion US dollars by June 2026. More pronounced growth is seen in inventories, which expanded from 298 million US dollars to 1.7 billion US dollars over the same period, indicating a substantial scaling of production or product pipeline expansion.
Long-Term Investment Strategy: A fundamental shift in the asset structure is evident in the growth of long-term marketable securities. This line item was negligible until December 2022 (112 million US dollars) but grew aggressively to 5.8 billion US dollars by June 2026. This indicates a transition from holding immediate cash to maintaining a diversified long-term investment portfolio.
Fixed and Intangible Assets: Property and equipment, net, show a steady climb from 986 million US dollars to 1.6 billion US dollars. A sharp increase in operating lease assets is observed in 2024, jumping from 312 million US dollars in March to 1.3 billion US dollars by September, suggesting significant new lease commitments. Deferred tax assets also grew substantially, rising from 815 million US dollars in March 2021 to over 3 billion US dollars by June 2026.

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

Balance Sheet: Assets
Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

Balance Sheet: AssetsQuarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data